134 related articles for article (PubMed ID: 2824549)
21. Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and alpha-subunit-secreting tumors from acromegalic patients responsive to octreotide.
Bertherat J; Turpin G; Rauch C; Li JY; Epelbaum J; Sassolas G; Schaison G
J Clin Endocrinol Metab; 1994 Nov; 79(5):1457-64. PubMed ID: 7962343
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin receptors in human endocrine tumors.
Reubi JC; Maurer R; von Werder K; Torhorst J; Klijn JG; Lamberts SW
Cancer Res; 1987 Jan; 47(2):551-8. PubMed ID: 3024822
[TBL] [Abstract][Full Text] [Related]
23. Evidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: affinity cross-linking and molecular characterization.
Murthy KK; Srikant CB; Patel YC
Endocrinology; 1989 Aug; 125(2):948-56. PubMed ID: 2568926
[TBL] [Abstract][Full Text] [Related]
24. Specific high affinity binding sites for somatostatin-28 on pancreatic beta-cells: differences with brain somatostatin receptors.
Reubi JC; Rivier J; Perrin M; Brown M; Vale W
Endocrinology; 1982 Mar; 110(3):1049-51. PubMed ID: 6120075
[TBL] [Abstract][Full Text] [Related]
25. [Receptor scintigraphy in endocrine gastrointestinal and pancreatic tumors].
Joseph K; Stapp J; Reinecke J; Höffken H; Benning R; Neuhaus C; Trautmann ME; Schwerk WB; Arnold R
Dtsch Med Wochenschr; 1992 Jun; 117(26):1025-8. PubMed ID: 1352234
[No Abstract] [Full Text] [Related]
26. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
[TBL] [Abstract][Full Text] [Related]
27. Quantitative in vivo autoradiographic localization of [125I-Tyr11]somatostatin-14- and [Leu8,D-Trp22-125I-Tyr25]somatostatin-28-binding sites in rat brain.
Patel YC; Baquiran G; Srikant CB; Posner BI
Endocrinology; 1986 Nov; 119(5):2262-9. PubMed ID: 2876887
[TBL] [Abstract][Full Text] [Related]
28. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
29. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
Bertherat J; Chanson P; Dewailly D; Dupuy M; Jaquet P; Peillon F; Epelbaum J
J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
[TBL] [Abstract][Full Text] [Related]
30. Expression of peptide receptors in human endocrine tumours of the pancreas.
Tang C; Biemond I; Lamers CB
Gut; 1997 Feb; 40(2):267-71. PubMed ID: 9071943
[TBL] [Abstract][Full Text] [Related]
31. Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain.
Raynor K; Reisine T
J Pharmacol Exp Ther; 1989 Nov; 251(2):510-7. PubMed ID: 2572690
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.
Moyse E; Le Dafniet M; Epelbaum J; Pagesy P; Peillon F; Kordon C; Enjalbert A
J Clin Endocrinol Metab; 1985 Jul; 61(1):98-103. PubMed ID: 2860120
[TBL] [Abstract][Full Text] [Related]
33. Characterization of covalently cross-linked somatostatin receptors in hamster beta cell insulinoma.
Cotroneo P; Marie JC; Rosselin G
Eur J Biochem; 1988 May; 174(1):219-24. PubMed ID: 2897292
[TBL] [Abstract][Full Text] [Related]
34. [Neuroendocrine tumors of the gastrointestinal tract].
Arnold C
Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
[TBL] [Abstract][Full Text] [Related]
35. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system.
Reubi JC; Lang W; Maurer R; Koper JW; Lamberts SW
Cancer Res; 1987 Nov; 47(21):5758-64. PubMed ID: 2889527
[TBL] [Abstract][Full Text] [Related]
36. Somatostatin (SRIH) messenger ribonucleic acid expression in human neuroendocrine and brain tumors using in situ hybridization histochemistry: comparison with SRIH receptor content.
Reubi JC; Waser B; Lamberts SW; Mengod G
J Clin Endocrinol Metab; 1993 Mar; 76(3):642-7. PubMed ID: 8095268
[TBL] [Abstract][Full Text] [Related]
37. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
38. Specific somatostatin receptors on human pituitary adenoma cell membranes.
Ikuyama S; Nawata H; Kato K; Karashima T; Ibayashi H; Nakagaki H
J Clin Endocrinol Metab; 1985 Oct; 61(4):666-71. PubMed ID: 2863281
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine tumours of the gut: long-term therapy with the somatostatin analogue SMS 201-995.
Anderson JV; Bloom SR
Scand J Gastroenterol Suppl; 1986; 119():115-28. PubMed ID: 2876495
[TBL] [Abstract][Full Text] [Related]
40. Somatostatin analogs in the management of gastrointestinal tumors.
Lamberts SW
Horm Res; 1988; 29(2-3):118-20. PubMed ID: 2900191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]